Xiaoling She
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Rheumatology top 5%
- Bone Tumor Diagnosis and Treatments
Papers in
-
- Circular RNAs in diseases 6
- Gut microbiota and health 2
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 9
- Co-authors
- Guiyuan Li (15 shared papers)Minghua Wu (17 shared papers)Guohua Lv (9 shared papers)Ming‐Xiang Zou (8 shared papers)Yi Jiang (7 shared papers)Yingnan Sun (8 shared papers)Peiyao Li (9 shared papers)Jing Li (6 shared papers)
- Journals
- Journal of Hematology & Oncology (3 papers)Neurosurgery (3 papers)Frontiers in Immunology (2 papers)Oncology Reports (1 paper)Drug Resistance Updates (1 paper)
- Partner nations
- ChinaSaudi ArabiaUnited States
In The Last Decade
Xiaoling She
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 89
- Cancer Research 518
- Rheumatology 173
- Reproductive Medicine 77
- Molecular Biology 627
- Immunology 171
Countries citing papers authored by Xiaoling She
This map shows the geographic impact of Xiaoling She's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling She with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling She more than expected).
Fields of papers citing papers by Xiaoling She
This network shows the impact of papers produced by Xiaoling She. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling She. The network helps show where Xiaoling She may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling She, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 97 | |
| 2 | 2011 | 85 | |
| 3 | 2018 | 73 | |
| 4 | 2018 | 61 | |
| 5 | 2018 | 57 | |
| 6 | 2021 | 54 | |
| 7 | 2014 | 53 | |
| 8 | 2016 | 53 | |
| 9 | 2018 | 51 | |
| 10 | 2014 | 47 | |
| 11 | 2015 | 44 | |
| 12 | 2017 | 42 | |
| 13 | 2018 | 40 | |
| 14 | 2018 | 39 | |
| 15 | 2019 | 37 | |
| 16 | 2016 | 36 | |
| 17 | 2012 | 34 | |
| 18 | 2016 | 33 | |
| 19 | 2017 | 33 | |
| 20 | 2020 | 31 |
About Xiaoling She
Xiaoling She is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Rheumatology and Immunology, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (9 papers), Bone Tumor Diagnosis and Treatments (6 papers), Circular RNAs in diseases (6 papers), Sarcoma Diagnosis and Treatment (3 papers), Endometriosis Research and Treatment (2 papers), Galectins and Cancer Biology (2 papers) and Gut microbiota and health (2 papers). The work is most often cited by research in Cancer Research (518 citations), Rheumatology (173 citations), Reproductive Medicine (77 citations), Molecular Biology (627 citations) and Immunology (171 citations). Xiaoling She has collaborated with scholars based in China, Saudi Arabia and United States. Frequent co-authors include Guiyuan Li, Minghua Wu, Guohua Lv, Ming‐Xiang Zou, Yi Jiang, Yingnan Sun, Peiyao Li, Jing Li, Changhong Liu and Zhibin Yu. Their work appears in journals such as Journal of Hematology & Oncology, Neurosurgery, Frontiers in Immunology, Oncology Reports and Drug Resistance Updates.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.